Abstract
Peripheral neuromodulation is derived from techniques used in traditional Chinese medicine, better known as acupuncture. The earliest writings about “stone needles” (called Pien in Chinese) date from about 500 BC. Puncturing specific points was believed to restore “the energetic harmony” of the body [1]. In 1683, Willem ten Rhijine discovered this Eastern traditional way of medicine and published a book entitled Dissertatio de Arthritide: Mantissa Schematica: De Acupunctura: Et Orationes tres [2]. He was the first Western physician to describe the technique he called “acupunctura,” where needles were used to treat a variety of diseases. One of the most common acupuncture points is the San-Yin-Jiao point or Spleen 6 (SP-6) located on the medial side of the lower leg, about 4 finger breadths cephalad to the medial malleolus. The location of SP-6 and the organs affected by its stimulation have remarkable similarities with current posterior tibia nerve stimulation (PTNS). In combination with the applied ground patch, an electrical current is applied to the acupuncture needle, which transforms into an electrical form of acupuncture.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Stux G. General standards in acupuncture treatment of chronic pain. Schmerz. 1997;11(2):126–7.
ten Rhijine W. Dissertatio de Arthritide: Mantissa Schematica: De Acupunctura: Et Orationes tres. Londini: Impensis R. Chiswell; 1683. p. 334.
McGuire EJ, Zhang SC, Horwinski ER, Lytton B. Treatment of motor and sensory detrusor instability by electrical stimulation. J Urol. 1983;129(1):78–9.
Stoller ML, Copeland S, Millard RJ, Murnaghan GF. The efficacy of acupuncture in reversing the unstable bladder in pig-tailed monkeys. J Urol. 1987;137(4):A104.
Cooperberg MR, Stoller ML. Percutaneous neuromodulation. Urol Clin N Am. 2005;32:71–8.
Chancellor MB, Chartier-Kastler EJ. Principles of sacral nerve stimulation (SNS) for the treatment of bladder and urethral sphincter dysfunctions. Neuromodulation. 2000;3(1):16–26.
Sillen U, Hjälmås K. Bladder function in preterm and full-term infants—free voidings during four-hour voiding observation. Scand J Urol Nephrol Suppl. 2004;215:63–8.
Yeung CK, Godley ML, Ho CK, Ransley PG, Duffy PG, Chen CN, et al. Some new insights into bladder function in infancy. Br J Urol. 1995;76(2):235–40.
Zotter H, Sauseng W, Kutschera J, Mueller W, Kerbl R. Bladder voiding in sleeping infants is consistently accompanied by a cortical arousal. J Sleep Res. 2006;15(1):75–9.
Kabay SC, Kabay S, Yucel M, Ozden H. Acute urodynamic effects of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson’s disease. Neurourol Urodyn. 2009;28:62–7.
Kabay SC, Yucel M, Kabay S. Acute effect of posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with multiple sclerosis: urodynamic study. Urology. 2008;71:641–5.
Gobbi C, Digesu GA, Khullar V, El Neil S, Caccia G, Zecca C. Percutaneous posterior tibial nerve stimulation as an effective treatment of refractory lower urinary tract symptoms in patients with multiple sclerosis: preliminary data from a multicentre, prospective, open label trial. Mult Scler. 2011;17:1514–9.
Andrews BJR, Reynard JM. Transcutaneous posterior tibial nerve stimulation for treatment of detrusor hyperreflexia in spinal cord injury. J Urol. 2003;170:926.
Govier FE, Litwiller S, Nitti V, Kreder KJ Jr, Rosenblatt P. Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study. J Urol. 2001;165:1193–8.
van Balken MR, Vergunst H, Bemelmans BLH. Prognostic factors for successful percutaneous tibial nerve stimulation. Eur Urol. 2006;49:360–5.
Kabay S, Kabay SC, Yucel M, Ozden H, Yilmaz Z, Aras O, et al. The clinical and urodynamic results of a 3 month percutaneous posterior tibial nerve stimulation treatment in patients with multiple sclerosis-related neurogenic bladder dysfunction. Neurourol Urodyn. 2009;28:964–8.
de Seze M, Raibaut P, Gallien P, Even-Schneider A, Denys P, Bonniaud V, et al. Transcutaneous posterior tibial nerve stimulation for treatment of the overactive bladder syndrome in multiple sclerosis: results of a multicenter prospective study. Neurourol Urodyn. 2011;30:306–11.
Danisman A, Kutlu O, Akkaya E, et al. Tibial nerve stimulation diminishes mast cell infiltration in the bladder wall induced by interstitial cystitis urine. Scand J Urol Nephrol. 2007;41:98–102.
Chang CJ, Huang ST, Hsu K, Stoller ML, Lue TF. Electroacupuncture decreases c-fos expression in the spinal cord induced by noxious stimulation of the rat bladder. J Urol. 1998;160:2274–9.
Finazzi-Agrò E, Rocchi C, Pachatz C, et al. Percutaneous tibial nerve stimulation produces effects on brain activity: study on the modifications of the long latency somatosensory evoked potentials. Neurourol Urodyn. 2009;28:320–4.
Zhang F, Zhao S, Shen B, et al. Neural pathways involved in sacral neuromodulation of reflex bladder activity in cats. Am J Physiol Renal Physiol. 2013;304:710–7.
Hotta H, et al. Age-related changes in neuromodulatory control of bladder micturition contractions originating in the skin. Front Neurosci. 2018;12:117.
Moya P, Parra P, Arroyo A, et al. Sacral nerve stimulation versus percutaneous posterior tibial nerve stimulation in the treatment of severe fecal incontinence in men. Tech Coloproctol. 2016;20(5):317–9.
Martinson M, MacDiarmid S, Black E. Cost of neuromodulation therapies for overactive bladder: percutaneous tibial nerve stimulation versus sacral nerve stimulation. J Urol. 2013;189(1):210–6.
Ahyai SA, et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol. 2010;58(3):384–97.
Deer T, et al. Prospective, multicenter, randomized, double-blinded, partial crossover study to assess the safety and efficacy of the novel neuromodulation system in the treatment of patients with chronic pain of peripheral nerve origin. Neuromodulation. 2016;19(1):91–100.
Heesakkers J, van Breda H, Van Kerrebroeck P, Digesu A, Elneil S. Safety and performance of a wireless implantable tibial nerve stimulator device for the treatment of patients with overactive bladder. Neurourol Urodyn. 2016;35(S4):S45–6.
https://www.jurology.com/article/S0022-5347(17)34414-2/abstract
https://www.meddeviceonline.com/doc/stimguard-receives-fda-ide-approval-to-launch-a-u-s-clinical-trial-for-a-revolutionary-wireless-device-to-alleviate-oab-symptoms-0001; https://www.mpo-mag.com/contents/view_breaking-news/2016-12-20/stimguard-enrolls-first-patient-in-office-based-chronic-tibial-nerve-oab-study
Kessler TM, Knuepfer S, De Wachter S, Kozomara M, Sievert K. Tibial neuromodulation: novel chronic implantable device achieves urinary continence in initial cases. Neurourol Urodynam. 2015;34(S3):S380 (abstract: 474). Abstract Montreal 2015.
Guzman-Negron J, Goldman HB. New devices and technologies for the management of overactive bladder. Curr Urol Rep. 2017;18:94.
van Breda HMK, et al. A new implanted posterior tibial nerve stimulator for the treatment of overactive bladder syndrome: 3-month results of a novel therapy at a single center. J Urol. 2017;198(1):205–10.
de Wall LL, Heesakkers JP. Effectiveness of percutaneous tibial nerve stimulation in the treatment of overactive bladder syndrome. Res Rep Urol. 2017;9:145–57.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature B.V.
About this chapter
Cite this chapter
Sievert, KD. (2019). Implantable Chronic Tibial Nerve Modulation (CTNM). In: Liao, L., Madersbacher, H. (eds) Neurourology. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-7509-0_39
Download citation
DOI: https://doi.org/10.1007/978-94-017-7509-0_39
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-7507-6
Online ISBN: 978-94-017-7509-0
eBook Packages: MedicineMedicine (R0)